Vista Capital Partners Inc. acquired a new position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) during the third quarter, HoldingsChannel reports. The fund acquired 5,831 shares of the company’s stock, valued at approximately $498,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. State Street Corp lifted its position in shares of Colgate-Palmolive by 97.4% during the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after purchasing an additional 46,476,510 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Colgate-Palmolive by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after purchasing an additional 1,010,872 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in shares of Colgate-Palmolive by 1.1% in the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after purchasing an additional 88,917 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Colgate-Palmolive by 17.4% in the first quarter. Bank of America Corp DE now owns 6,637,597 shares of the company’s stock valued at $565,722,000 after purchasing an additional 986,063 shares in the last quarter. Finally, Amundi raised its position in Colgate-Palmolive by 19.9% in the 2nd quarter. Amundi now owns 6,218,257 shares of the company’s stock worth $570,090,000 after purchasing an additional 1,033,918 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Stock Down 0.1%
Shares of NYSE:CL opened at $99.62 on Monday. Colgate-Palmolive Company has a one year low of $75.96 and a one year high of $101.18. The company has a 50 day moving average of $90.94 and a 200-day moving average of $90.29. The company has a debt-to-equity ratio of 11.23, a current ratio of 0.96 and a quick ratio of 0.63. The stock has a market cap of $79.19 billion, a price-to-earnings ratio of 39.07, a P/E/G ratio of 4.51 and a beta of 0.31.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. During the same period in the prior year, the business posted $0.91 earnings per share. Colgate-Palmolive’s revenue was up 4.6% compared to the same quarter last year. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.92 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th were issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, October 20th. Colgate-Palmolive’s payout ratio is currently 83.14%.
Insider Buying and Selling at Colgate-Palmolive
In other news, EVP Gregory Malcolm sold 4,100 shares of the firm’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total value of $401,677.00. Following the transaction, the executive vice president directly owned 10,061 shares in the company, valued at $985,676.17. This trade represents a 28.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider John Hazlin sold 23,376 shares of Colgate-Palmolive stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $99.15, for a total value of $2,317,730.40. Following the sale, the insider directly owned 27,021 shares of the company’s stock, valued at approximately $2,679,132.15. This trade represents a 46.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 77,414 shares of company stock worth $7,613,786. 0.43% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several research firms have issued reports on CL. Royal Bank Of Canada upped their price objective on Colgate-Palmolive from $104.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, November 2nd. Weiss Ratings cut Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Barclays lifted their target price on Colgate-Palmolive from $87.00 to $95.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 3rd. TD Cowen boosted their target price on Colgate-Palmolive from $90.00 to $97.00 and gave the stock a “hold” rating in a research report on Monday, November 2nd. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Thirteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $101.22.
Get Our Latest Stock Analysis on CL
Key Stories Impacting Colgate-Palmolive
Here are a few of the latest stories about CL:
- Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85, close to the $3.92 consensus, and nudged its FY2027 and FY2028 forecasts higher to $4.06 and $4.38, respectively. These revisions suggest modest confidence in longer-term earnings growth. Zacks Research Has Bullish Forecast for CL FY2026 Earnings
- Neutral Sentiment: A comparison with Kimberly-Clark highlighted Colgate-Palmolive’s leading global oral-care position and its pet-nutrition business as potential growth diversifiers, but the article did not report a new company-specific catalyst. Colgate-Palmolive vs. Kimberly-Clark
- Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company shares. Insider sales can weigh on sentiment, although a single transaction does not necessarily indicate a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells Stock
Colgate-Palmolive Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Read More
- Five stocks we like better than Colgate-Palmolive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
